Search alternatives:
greater decrease » greatest decrease (Expand Search), greater increase (Expand Search), greater disease (Expand Search)
nn decrease » _ decrease (Expand Search), gy decreased (Expand Search), b1 decreased (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
greater decrease » greatest decrease (Expand Search), greater increase (Expand Search), greater disease (Expand Search)
nn decrease » _ decrease (Expand Search), gy decreased (Expand Search), b1 decreased (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
-
1341
-
1342
Supplementary Material for: Allopurinol Use is Associated With Decreased Incidence of Hepatic Decompensation and Overall Mortality Among Individuals With Cirrhosis: a Propensity-ma...
Published 2025“…Conclusion: In a propensity-score matched analysis of a large national database, individuals with cirrhosis and allopurinol use had significantly lower risk of hepatic decompensation and overall mortality. …”
-
1343
-
1344
Table 1_A novel α-conotoxin [D1G, ΔQ14] LvIC decreased mouse locomotor activity.xls
Published 2025“…</p>Results<p>The injection of [D1G, ΔQ14] LvIC led to a decrease in locomotor activity in mice. This treatment also resulted in reduced expression of neuronal calcium sensor 1 (NCS-1) and neuroligin 3 (NLGN-3) in the prefrontal cortex (PFC), hippocampus (Hip), and caudate putamen (CPu). …”
-
1345
Table 2_A novel α-conotoxin [D1G, ΔQ14] LvIC decreased mouse locomotor activity.xls
Published 2025“…</p>Results<p>The injection of [D1G, ΔQ14] LvIC led to a decrease in locomotor activity in mice. This treatment also resulted in reduced expression of neuronal calcium sensor 1 (NCS-1) and neuroligin 3 (NLGN-3) in the prefrontal cortex (PFC), hippocampus (Hip), and caudate putamen (CPu). …”
-
1346
-
1347
-
1348
-
1349
Meta-analysis showing the overall effect of different statin types versus placebo for
Published 2025Subjects: -
1350
-
1351
-
1352
-
1353
-
1354
Version 2 of the Cochrane risk-of-bias tool for randomized controlled trials.
Published 2025Subjects: -
1355
Analysis of randomized controlled trials stratified based on treatment duration.
Published 2025Subjects: -
1356
-
1357
-
1358
-
1359
-
1360
Summary table showing analysis of randomized controlled trials stratified based on age groups.
Published 2025Subjects: